Navigation Links
EnVivo Pharmaceuticals Announces Significant Results from GSM Transgenic Mouse Model for Alzheimer's Disease
Date:7/14/2010

HONOLULU, July 14 /PRNewswire/ -- EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease (ICAD) results from its proprietary gamma-secretase modulator (GSM) pre-clinical study.  In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.

EVP-0015962 is a proprietary small molecule compound that belongs to a new generation of potential Alzheimer's drugs known as gamma-secretase modulators.  EVP-0015962 selectively inhibits the production of the toxic aggregated amyloid AB42 peptide without affecting the total amount of AB.  As EVP-0015962 does not affect other gamma secretase substrates required for normal function, such as Notch, it is predicted to slow the progression of Alzheimer's disease by reducing the disease-associated toxic AB42 species.

In its study, EnVivo was able to show that EVP-0015962 significantly reduced the production of total amyloid load as measured by plaque count, surface area and aggregated AB in the brains of transgenic mice after 12 months of daily oral administration.  In the same model, mice developed deficits in the hippocampal memory task known as contextual fear conditioning.  Chronic dosing with EVP-0015962 reversed these deficits returning the cognitive function to normal levels.  In addition, EVP-0015962 reduced the amount of brain inflammation associated with amyloid plaque buildup in these animals.

These findings demonstrate continued positive effects in transgenic Alzheimer's animals with EVP-0015962.  Given the multiple positive results from this and previous studies, EnVivo is confid
'/>"/>

SOURCE EnVivo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
2. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 /CNW/ - ChipCare Corporation, a University of ... for HIV and other infectious and non-communicable diseases ... to bring its first-generation product to market while ... (Photo: http://photos.prnewswire.com/prnh/20150303/179107 ) ... simple, accurate and affordable diagnostic tests makes it ...
(Date:3/3/2015)... -- Tru-D SmartUVC will exhibit the cutting-edge UV disinfection ... Surgical Conference and Expo 2015 in ... Week March 7 through 11. AORN provides perioperative ... professional development. Photo - ... Tru-D SmartUVC,s UV light disinfection ...
(Date:3/3/2015)...  Delcath Systems, Inc. (NASDAQ: DCTH ... focused on oncology with an emphasis on the ... that the results from its Phase 3 clinical ... submitted for publication in a leading peer-reviewed medical ... Injection for use with the Delcath Hepatic Delivery ...
Breaking Medicine Technology:ChipCare Closes Oversubscribed $5 Million Series A Financing 2ChipCare Closes Oversubscribed $5 Million Series A Financing 3Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 2Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 2Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 4
... 18 Telik, Inc.,(Nasdaq: TELK ) announced ... small molecule kinase inhibitors will be presented at ... in,San Francisco. The presentation, "In Vitro and Vivo ... VEGFR2" (Abstract # C206) will be,on Thursday, October ...
... MRSA, WASHINGTON, Oct. 18 Building on the ... infection by 50 percent,the Department of Veterans Affairs (VA) ... of its 153 hospitals., In addition to emphasizing ... special precautions, VA facilities monitor,all incoming patients on key ...
Cached Medicine Technology:VA National Campaign Takes Aim at Resistant Staph Infections 2
(Date:3/3/2015)... March 03, 2015 In March, 1% ... networks, will kick off a new campaign, “Know Your Source,” ... businesses, nonprofits, and ambassadors in their quest for ingredient awareness ... with several of its members and partners, including King Arthur ... Once network, to raise awareness for food as an environmental ...
(Date:3/3/2015)... 2015 While it is clear that ... why young Canadian drivers are signing up to UBI ... proposition to be enticed. Due to current regulations, the ... stripped-back form. Its full capability is starting to ... predictive maintenance, emergency breakdown services are at the top ...
(Date:3/3/2015)... MD (PRWEB) March 03, 2015 Today ... Association (ASHA) is using the occasion to applaud and ... campaign by the World Health Organization (WHO) for stemming ... campaign aims to encourage young people to practice safe ... audio technology, attending concerts or sporting events, or engaging ...
(Date:3/3/2015)... Calif. (PRWEB) March 03, 2015 The Calistoga ... area, “Mudder of All Weekends,” taking place Friday, March 27, ... scavenger hunt, Pretty Muddy 5K fun run, restaurant and bar ... event is open to women, ages 14 and older. , ... are getting in on the action by offering Mudder ...
(Date:3/3/2015)... MI (PRWEB) March 03, 2015 In ... News Morning Edition, science correspondent Shankar Vedantam shared ... of Pennsylvania about the drastic decrease in hand-hygiene compliance that ... suggested that the problem could be solved in part by ... hand hygiene when they enter and exit a patient’s room. ...
Breaking Medicine News(10 mins):Health News:1% For the Planet Asks Consumers to “Know Your Source” 2Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 3Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3
... Rapid Advances in Nation,s 4th Leading Cancer Killer, ... Foundation for,Pancreatic Cancer Research, the largest private foundation ... its,Year 2009 Request For Proposals (RFP) to identify ... of cancer deaths in the United,States., The ...
... June 21, 2008, New Alternatives,for Children (NAC), a New ... disabilities and/or chronic illnesses, will,hold its 3rd Annual NAC ... 12:00 noon to 3:30 pm rain or shine., ... family members,are expected to participate in the 2008 NAC ...
... to fight tumors. Often, tumors have more than one way ... Now, in a new study, University of Missouri researchers have ... cells, by combining a small molecular drug that targets tumor ... blood vessels. , In 50 percent of breast cancer cases, ...
... June 18 Movement Against Cancer,(MAC), cancer patient advocacy ... urge people in Russia to undergo early screening,tests and ... prostate cancer and cervical cancer -- the types of ... of the most serious problems with cancer treatment in ...
... who dropped most pounds went off diabetes meds ... (HealthDay News) -- Weight loss plays a major role ... say Duke University Medical Center researchers. , Previous ... re-routes how food is sent from the stomach to ...
... more than two years ago at Children,s Hospital ... between caregivers and patients and improved patient and ... found. , Children,s Hospital became the first pediatric ... King Foundation to launch a patient safety initiative ...
Cached Medicine News:Health News:Lustgarten Foundation Announces 2009 Request for Proposals (RFP) 2Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 2Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 3Health News:New cancer treatment targets both tumor cells and blood vessels 2Health News:Movement Against Cancer Launches An All-Russia Cancer Awareness Campaign to Promote Early Screening and Cancer Detection Programs in Russia's Regions 2Health News:Weight Loss After Gastric Bypass Is Key to Easing Diabetes 2Health News:Study finds Children's Hospital patient safety program improves caregiver/family communications 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: